SP1 and hepatitis B virus infection: In fact, SP1-mediated HBV replication can be targeted with drugs that can treat hepatitis B. Screening for alpha-glucosidase (AG) inhibitors against the HBV infection in hepatocytes identified one candidate inhibitor that lowered ccc DNA production through binding to SP1 [200].